Aytu BioPharma (AYTU) Stock Highlights

2.47 | -2.37%

2024-09-19 07:02:12

Aytu BioPharma Inc is a specialty pharmaceutical company with a commercial portfolio of prescription therapeutics and consumer health products. The companys primary prescription products treat attention deficit hyperactivity disorder and other common pediatric conditions. It is building a complimentary therapeutic development pipeline including a prospective treatment (AR101/enzastaurin) for vascular Ehlers-Danlos Syndrome, a rare genetic disease resulting in high morbidity and a significantly shortened lifespan. AR101/enzastaurin has received Orphan Drug designation from the FDA. The company operates in two segments BioPharma and Consumer Health segments of which it generates maximum revenue from the BioPharma segment.

Statistics

Range Today

2.45 2.53

Volume Today 13.3K

Range 1 Year

1.53 3.5

Volume 1 Year 14.45M

Range 3 Year

1.38 65.8

Volume 3 Year 39.61M

Range 10 Year

1.38 11331800

Volume 10 Year 60.14M

Highlights

Market Capitalization 15.41M (micro)

Floating Shares 3.98M

Current Price 2.47

Price To Earnings -1.05

Price To Revenue 0.14

Price To Book 0.47

Earnings Per Share -2.44

Payout Ratio 0%

Performance

Latest -2.37%

1 Month -8.18%

3 Months -17.39%

6 Months -12.41%

1 Year +48.8%

3 Years -95.96%

5 Years -99.15%

10 Years -100%

Benchmarks

Market Capitalization

336 / 368

Gross Profits

56 / 278

Total Revenue

90 / 300

Total Rank

214 / 368

Free Cashflow

33 / 352

Performance 5 years

359 / 368

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.